Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome

By Kazerooni T.   Dehghan-Kooshkghazi M.  

Gynecological Endocrinology, Vol. 17, Iss. 1, 2003-02 ,pp. : 51-56

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study

By Cinar Nese   Harmanci Ayla   Demir Basaran   Yildiz Bulent O.  

Human Reproduction, Vol. 27, Iss. 6, 2012-06 ,pp. : 1840-1845

Oxford University Press

Access to resources Recommend Favorite

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

By Kaltsas T  

Human Reproduction, Vol. 13, Iss. 1, 1998-01 ,pp. : 22-26

Oxford University Press

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite